Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cubicin (Royalty rights)

M&A STATUS
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

A portfolio of royalty interests in an antibiotic drug. The portfolio comprises royalty rights in Cubicin, an antibiotic in a class of anti-infectives called lipopeptides.

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Other Business Products and Services
Acquirer
Primary Office
  • United States

Cubicin (Royalty rights) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Cubicin (Royalty rights)‘s full profile, request access.

Request full access to PitchBook